Oxify Lidocaine 5% Cream

Manufacturer
Weeks & Leo Compnay, INC. | Weeks & Leo Co., Inc.
Effective date
2026-10-06
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
daily-update
Hydrated at
2026-10-10 01:03:47

Label at a glance#

ProductOxify
Active ingredientLIDOCAINE
Label structure11 sections

Storage and handling

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controoled Room Temperature]

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 5% w/w

OTC - PURPOSE SECTION

Local anesthetic

OTC - QUESTIONS SECTION

Call 833-358-6431

WARNINGS SECTION

For External use only

OTC - WHEN USING SECTION

  • Avoid contact with eyes
  • do not exceed recommended dosage unless directed by a doctor
  • do not put this product into the rectum by using fingers or any mechanical device or applicator

OTC - STOP USE SECTION

  • rectal bleeding occurs
  • condition worsens or does not improve within 7 days
  • symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase
  • symptoms clear up and return within a few days

OTC - ASK DOCTOR SECTION

  • rectal bleeding occurs
  • condition worsens or does not improve within 7 days
  • symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase
  • symptoms clear up and return within a few days

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

  • when practical, clean area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or soft cloth before applying
  • adults and children 12 years and over: apply externally to the affected area up to 6 times a day
  • children under 12 years: consult a doctor

INDICATIONS & USAGE SECTION

Helps relieve the pain, itching, and burning associated with hemorrhoids and other anorectal disorders

STORAGE AND HANDLING SECTION

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controoled Room Temperature]

OTHER SAFETY INFORMATION

Allergy alert: certain persons can develop allergic reactions to ingredients in this product.

INACTIVE INGREDIENT SECTION

acrylates/C10-30 alkyl acrylate crosspolymer, aloe barbedenisis (aloe vera) leaf juice, benzyl alcohol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, edetate disodium, ethylhexylglycerin, glyceryl stearate, isopropyl myristate, methylparaben, propylene glycol, steareth – 21, tocopheryl acetate, trolamine, water

RECENT MAJOR CHANGES SECTION

Changed Administration section to dosage and administration section

updated a spelling error in Directions toiled to toilet

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PDPPDP

Oxify

Lidocaine 5%

Anorectal (Hemorrhoidal) Cream

Relieves Pain, Itching, Burning

Net Wt. 6 oz (170 g)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11383-33111383-331-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxifyLIDOCAINE 5%Weeks & Leo Compnay, INC.5d31cf09-5a67-d308-e063-6294a90af8542026-10-06WarningsExact identifier
ndc (package): 11383-331-06
ndc (product): 11383-331
ndc11 (package): 11383033106
spl id: 5d31cf1b-7684-0573-e063-6394a90a7123
spl set id: 5d31cf09-5a67-d308-e063-6294a90af854

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.